Methamphetamine stays in your system for approximately:
|Hair:||Up to 90 days|
The amount of time that meth stays in your system depends on the dose ingested, frequency of use, and your body’s ability to process it.
Methamphetamine is the second most popular illicit drug in the world, after marijuana. It is commonly sold under the street names meth, crank, crystal, crystal meth, glass, ice, and speed.
In the United States, it is considered a schedule II drug, meaning it has a high potential for misuse and a high risk for developing a severe mental or physical dependence (addiction).
It does have limited medical usage and can be prescribed under the brand name Desoxyn to treat ADHD or obesity. However, it is rarely prescribed as safer drugs such as Adderall and Ritalin are now available.
Methamphetamine increases the brain’s production of dopamine, a chemical that is involved in body movement, motivation, and rewarding behaviors. It is a central nervous system stimulant.
Adverse short-term side effects of meth use include:
Adverse long-term side effects of meth abuse include:
Psychosis has been reported as an effect of long term use. Psychosis is a severe mental disorder that impairs your thoughts and emotions so much that you lose contact with external reality. Meth-induced psychosis can occur during intoxication or afterward during withdrawal.
Crystal meth is one of the most addictive drugs in the world. Because it has such a powerful effect on the brain’s reward system, even first-time meth users have a very strong drive to use it again. After just a few uses, people can develop psychological or physical dependence, especially if the drug is smoked or injected.
Because the physical addiction to meth is very intense, withdrawal symptoms are also severe. Withdrawal symptoms can begin approximately 24 hours after the last dose. Generally, the heavier the drug use, the worse your symptoms will be.
Meth withdrawal symptoms include:
Users can inject, smoke, swallow, or snort methamphetamine. Injecting or smoking will cause the drug to reach the brain very quickly, causing a “rush” or “flash” of euphoria. The high will be more intense but wear off quicker. Swallowing or snorting the drug will cause the high to be spread out up to 12 hours, and aftereffects can last up to 24 hours.
The half-life of methamphetamine is approximately 10 hours. This means that after 10 hours, half of the ingested dose has been metabolized and removed from the bloodstream.
After ingestion, meth enters your urine, sweat, blood, and hair. All hair and fluid samples can be tested for meth. However, urine testing is the most common and cost-effective type of drug test for methamphetamine.
Meth will show up in your urine within an hour of ingesting the drug. A urine test can detect meth one to three days after the last use for occasional users, and seven to ten days for very heavy users
Meth typically leaves your bloodstream completely after 48 hours. However, a blood test may be able to detect it after three to four days in chronic users who ingest large doses.
Meth remains in your saliva for one to four days after the last use. A cotton swab can collect oral fluid from your mouth for a saliva test.
Meth reaches your hair follicles seven to ten days after use and remains in them for up to 90 days. However, hair tests are typically more expensive than other methods of testing. Further, their results are more controversial as environmental contamination may cause false positives.
The length of time depends on the dose ingested, frequency of use, and your body’s ability to process it, but meth typically stays in your urine for 1-10 days, blood for 1-3 days, saliva 1-4 days and hair up to 90 days.
Meth addiction is treated similarly to most substance use disorders. While there is no FDA-approved medication to treat methamphetamine use, there is a wide range of addiction treatment programs that help individuals recover through detox, behavioral therapy, and peer support.
A comprehensive program at an inpatient treatment facility provides the best hope for meth recovery.
NIDA. "Methamphetamine." National Institute on Drug Abuse, 16 May. 2019, https://www.drugabuse.gov/publications/drugfacts/methamphetamine.
Barnes, Allan J et al. “Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration.” Clinical chemistry vol. 54,1 (2008): 172-80. doi:10.1373/clinchem.2007.092304, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714868/
Huestis, Marilyn A, and Edward J Cone. “Methamphetamine disposition in oral fluid, plasma, and urine.” Annals of the New York Academy of Sciences vol. 1098 (2007): 104-21. doi:10.1196/annals.1384.038, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709797/
Kish, Stephen J. “Pharmacologic mechanisms of crystal meth.” CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne vol. 178,13 (2008): 1679-82. doi:10.1503/cmaj.071675, https://pubmed.ncbi.nlm.nih.gov/18559805/
Zorick, Todd et al. “Withdrawal symptoms in abstinent methamphetamine-dependent subjects.” Addiction (Abingdon, England) vol. 105,10 (2010): 1809-18. doi:10.1111/j.1360-0443.2010.03066.x, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071736/
NIDA. "Methamphetamine." National Institute on Drug Abuse, 16 Oct. 2019, https://www.drugabuse.gov/publications/research-reports/methamphetamine.
Courtney, Kelly E, and Lara A Ray. “Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.” Drug and alcohol dependence vol. 143 (2014): 11-21. doi:10.1016/j.drugalcdep.2014.08.003, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164186/
Glasner-Edwards, Suzette, and Larissa J Mooney. “Methamphetamine psychosis: epidemiology and management.” CNS drugs vol. 28,12 (2014): 1115-26. doi:10.1007/s40263-014-0209-8, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027896/